» Articles » PMID: 38504946

Hemodynamic Monitoring Using a Pulmonary Artery Catheter Versus the Vigileo/FloTrac System During Elective Cardiac Surgery Based on Real-world Data in Japan

Overview
Specialty General Medicine
Date 2024 Mar 20
PMID 38504946
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The controversy concerning the benefits of pulmonary artery catheter (PAC)-based hemodynamic monitoring in cardiac surgeries has not been adequately addressed. This study aims to compare the all-cause mortality between the PAC with venous oxygen saturation monitoring and the Vigileo/FloTrac (FloTrac) system with central venous oxygen saturation monitoring in cardiac surgeries.

Methods: This nationwide retrospective study includes adult patients who underwent elective cardiac surgeries between April 2010 and October 2014, based on the Japanese health insurance claims database. The main outcome was 30-day all-cause mortality. Propensity scores (PS) were used to adjust for the confounding factors. Treatment effects were estimated using multivariable logistic regression analysis, including PS.

Results: A total of 5,838 patients were included in this study. The crude 30-day mortality rates were 2.4% (8/334) and 1.7% (96/5,504) in the FloTrac and PAC groups, respectively. After PS matching, the ORs for 30-day all-cause mortality, in-hospital mortality after PAC placement (vs. FloTrac) were 0.36 (95% CI: 0.05-2.37; p = 0.28) and 0.59 (95% CI: 0.16-2.20; p = 0.43), respectively. The amount of dobutamine was larger in the PAC group (281 ± 31 mg vs 155 ± 19 mg; p < 0.001). There were no significant differences in the amounts of other inotropes, the volume of fluids, or blood transfusions.

Conclusions: The association between PAC (with venous oxygen saturation monitoring) and mortality in patients who underwent elective cardiac surgeries was unclear compared to FloTrac (with central venous oxygen saturation monitoring). Additional investigation is needed to evaluate the benefits of PAC-specific hemodynamic parameters in this population.

References
1.
Desebbe O, Henaine R, Keller G, Koffel C, Garcia H, Rosamel P . Ability of the third-generation FloTrac/Vigileo software to track changes in cardiac output in cardiac surgery patients: a polar plot approach. J Cardiothorac Vasc Anesth. 2013; 27(6):1122-7. DOI: 10.1053/j.jvca.2013.03.008. View

2.
Koo K, Sun J, Zhou Q, Guyatt G, Cook D, Walter S . Pulmonary artery catheters: evolving rates and reasons for use. Crit Care Med. 2011; 39(7):1613-8. DOI: 10.1097/CCM.0b013e318218a045. View

3.
DAgostino Jr R . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81. DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b. View

4.
Wiener R, Welch H . Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA. 2007; 298(4):423-9. DOI: 10.1001/jama.298.4.423. View

5.
Sandham J, Hull R, Brant R, Knox L, Pineo G, Doig C . A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003; 348(1):5-14. DOI: 10.1056/NEJMoa021108. View